Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
Conditions
- Cancer Related Cardiovascular Toxicity
Interventions
- COMBINATION_PRODUCT: Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy
Sponsor
University of Bologna
Collaborators